Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 3/2018

01-05-2018 | Laboratory Investigation

Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma

Authors: Yang Yuan, Li Jiaoming, Wang Xiang, Liu Yanhui, Jiang Shu, Gou Maling, Mao Qing

Published in: Journal of Neuro-Oncology | Issue 3/2018

Login to get access

Abstract

Cross-talk between competitive endogenous RNAs (ceRNAs) may play a critical role in revealing potential mechanisms of tumor development and physiology. Glioblastoma is the most common type of malignant primary brain tumor, and the mechanisms of tumor genesis and development in glioblastoma are unclear. Here, to investigate the role of non-coding RNAs and the ceRNA network in glioblastoma, we performed paired-end RNA sequencing and microarray analyses to obtain the expression profiles of mRNAs, lncRNAs, circRNAs and miRNAs. We identified that the expression of 501 lncRNAs, 1999 mRNAs, 2038 circRNAs and 143 miRNAs were often altered between glioblastoma and matched normal brain tissue. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed on these differentially expressed mRNAs and miRNA-mediated target genes of lncRNAs and circRNAs. Furthermore, we used a multi-step computational framework and several bioinformatics methods to construct a ceRNA network combining mRNAs, miRNAs, lncRNAs and circRNA, based on co-expression analysis between the differentially expressed RNAs. We identified that plenty of lncRNAs, CircRNAs and their downstream target genes in the ceRNA network are related to glutamatergic synapse, suggesting that glutamate metabolism is involved in glioma biological functions. Our results will accelerate the understanding of tumorigenesis, cancer progression and even therapeutic targeting in glioblastoma.
Appendix
Available only for authorised users
Literature
1.
Venkatesh T, Suresh PS, Tsutsumi R (2015) Non-coding RNAs: functions and applications in endocrine-related cancer. Mol Cell Endocrinol 416(1):1–21
2.
Sumazin P et al (2011) An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Can Res 147(2):370–381
3.
Chen Y, Li C, Tan C, Liu X (2016) Circular RNAs: a new frontier in the study of human diseases. J Med Genet 53(6):359–365CrossRefPubMed
4.
Li JH, Liu S, Zhou H, Qu LH, Yang JH (2013) Starbase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale clip-seq data. Nucleic Acids Res 42(D1): 92–97CrossRef
5.
Ju YP, Lee JE, Park et al (2014) Roles of long non-coding RNAs on tumorigenesis and glioma development. Brain Tumor Res Treat (1):1–6
6.
7.
8.
9.
Thomson DW, Dinger ME (2016) Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 17(5):272 –283CrossRefPubMed
10.
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J et al (2015) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25(8):981CrossRefPubMedPubMedCentral
11.
Shao T, Wu A, Chen J, Chen H, Lu J, Bai J et al (2015) Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma. Mol Biosyst 11(11):3048–3058CrossRefPubMed
12.
Dou C, Cao Z, Yang B, Ding N, Hou T, Luo F et al (2016) Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis. Sci Rep 6:21499CrossRefPubMedPubMedCentral
13.
Wang PF, Liu N, Song HW, Yao K, Jiang T, Li SW et al (2016) Idh-1r132h mutation status in diffuse glioma patients: implications for classification. Oncotarget 7(21):31393–31400PubMedPubMedCentral
14.
Zou P, Xu H, Chen P, Yan Q, Zhao L, Zhao P et al (2013) Idh1/idh2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis. PLoS ONE 8(7):e68782–e68782CrossRefPubMedPubMedCentral
15.
Li Y, Wang Z, Wang Y, Zhao Z, Zhang J, Lu J et al (2016) Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma. Oncotarget 19(29):45027–45041
16.
Han L, Zhang K, Shi Z, Zhang J et al (2012) LncRNA profile of glioblastoma reveals the potential role of lncRNAs, in contributing to glioblastoma pathogenesis. Int J Oncol 40(6):2004–2012PubMed
17.
Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A et al (2013) String v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41(Database issue):808–815
18.
Kanehisa M, Araki M, Goto S et al (2008) Kegg for linking genomes to life and the environment. Nucleic Acids Res 36(1):d480–d484
19.
Wagle N, Berger MF, Davis MJ, Blumenstiel B, Defelice M, Pochanard P et al (2012) High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov 2(1):82–93CrossRefPubMed
20.
Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10(3):1–10CrossRef
21.
22.
Mao BX, Cai T, Olyarchuk J, Wei (2005) L: Automated genome annotation and pathway identification using the KEGG orthology (KO) as a controlled vocabulary. Bioinformatics 21(19):3787–3793CrossRefPubMed
23.
Mortazavi A, Williams BA, Mccue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-seq. Nat Methods 5(7):621–628CrossRefPubMed
24.
Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L (2010) Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28(5):511–515CrossRefPubMedPubMedCentral
25.
26.
Jin M, Zhang T, Liu C, Badeaux M et al (2014) MiRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 74(15):4183–4195CrossRefPubMedPubMedCentral
27.
Cheng CJ, Bahal R, Babar IA et al (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518(7537):107–110CrossRefPubMed
28.
Tay Y, Kats L, Salmena L, Weiss D et al (2011) Coding-independent regulation of the tumor suppressor pten by competing endogenous mRNAs. Cell 147(2):344–357CrossRefPubMedPubMedCentral
29.
Yan Y, Zhang L, Jiang Y, Xu T, Mei Q, Wang H et al (2015) LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme. J Cancer Res Clin Oncol 141(5):827–838CrossRefPubMed
30.
Johnstone KA, Dubose AJ, Futtner CR, Elmore MD, Brannan CI, Resnick JL (2006) A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for angelman syndrome imprinting defects. Hum Mol Genet 15(3):393–404CrossRefPubMed
31.
Sutherland HF, Wadey R, Mckie JM, Taylor C, Atif U, Johnstone KA et al (1996) Identification of a novel transcript disrupted by a balanced translocation associated with digeorge syndrome. Am J Hum Genet 59(1):23–31PubMedPubMedCentral
32.
Willingham AT, Schultz PG (2005) A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309(5740):1570–1573CrossRefPubMed
33.
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384–388CrossRefPubMed
34.
Zhao ZJ, Shen J (2015) Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol 4(3):501–589
35.
Xu H, Guo S, Li W, Yu P (2015) The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci Rep 5(1):385–393
36.
Le TD, Zhang J, Liu L, Li J (2016) Computational methods for identifying miRNA sponge interactions. Brief Bioinform 18(4):577–590
37.
Cao Y, Wang P, Ning S, Xiao W, Xiao B, Li X (2016) Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Oncotarget 5(27):41737–41747
38.
Metadata
Title
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma
Authors
Yang Yuan
Li Jiaoming
Wang Xiang
Liu Yanhui
Jiang Shu
Gou Maling
Mao Qing
Publication date
01-05-2018
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-018-2757-0

Other articles of this Issue 3/2018

Journal of Neuro-Oncology 3/2018 Go to the issue

Laboratory Investigation

The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells

Topic Review

Tumor treating fields: a new approach to glioblastoma therapy

Clinical Study

Neurologic complications of immune checkpoint inhibitors

Letter to the Editor

Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules

Clinical Study

Personality traits, patient-centered health status and prognosis of brain tumor patients

Clinical Study

Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database